Genome Sequencing Readily Detects a Copy Number Variant in FBN1 in a Patient with Marfan Syndrome
Marfan syndrome is characterized by musculoskeletal, ocular, and cardiovascular findings and results from heterozygous disease-causing variants in FBN1 (fibrillin-1). Given that the majority of pathogenic variants in FBN1 are single-nucleotide variants (SNVs) or variants smaller than 50 base pairs, routine clinical genetic testing is optimized for these variant types. Here, we present an individual with a clinical diagnosis of Marfan syndrome, in whom routine commercial testing was nondiagnostic.
Authors
- Francesca Jean
- Julien Marcadier
- Francois P. Bernier
- Amanda Stuart
- Ryan E. Lamont
Institutions
- University of Calgary (CA)
- Alberta Children's Hospital (CA)
Publication Details
- Journal
- CJC Open
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.cjco.2026.01.012
- Primary Topic
- Connective tissue disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Genome Canada
- Children's Hospital Foundation
- Ontario Genomics
- Ontario Genomics Institute
- Genome British Columbia
- Alberta Children's Hospital Foundation
- Genome Alberta
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada